Reassessing Immunity: A New Perspective on COVID Treatment

This chapter features a Johns Hopkins doctor discussing a new Merck COVID treatment drug that reduces mortality rates, while challenging beliefs about the efficacy of natural immunity compared to vaccinations. It highlights the need for science-based vaccine policies that consider natural immunity and addresses concerns about vaccine safety amidst rising infection rates.